Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Buy
8,213
+7,582
+1,202% +$167K ﹤0.01% 2166
2026
Q1
$9.23K Buy
631
+396
+169% +$5.81K ﹤0.01% 2481
2025
Q4
$2.97K Sell
235
-800
-77% -$11.8K ﹤0.01% 3103
2025
Q3
$15.9K Buy
1,035
+810
+360% +$13.1K ﹤0.01% 2378
2025
Q2
$3.54K Buy
225
+212
+1,631% +$3.21K ﹤0.01% 2364
2025
Q1
$249 Sell
13
-81
-86% -$1.77K ﹤0.01% 2588
2024
Q4
$2.24K Hold
94
﹤0.01% 1986
2024
Q3
$2.63K Hold
94
﹤0.01% 1958
2024
Q2
$2.46K Buy
+94
New +$1.96K ﹤0.01% 1891

Other funds holding RXO

Arax Advisory Partners's RXO Position: Q2 2026 in Review

Arax Advisory Partners increased its RXO (RXO) stake by 1,202% in Q2 2026, buying an estimated $167K and bringing the position to 8,213 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

Arax Advisory Partners first reported a position in RXO in Q2 2024 and has held it in 9 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Arax Advisory Partners held 8,213 shares of RXO worth $227K as of Q2 2026.
  • Arax Advisory Partners bought 7,582 RXO shares in Q2 2026, an estimated $167K.
  • RXO made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2166 holding.
  • Arax Advisory Partners first reported a position in RXO in Q2 2024 and has held it in 9 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.